Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
Proteome Science|December 31, 2011
S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cellsSayo Suzuki, Yasuko Yamayoshi, Akito Nishimuta, et al.Therapeutic Drug Monitoring|September 18, 2020
Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage OptimizationPrawat Chantharit, Montira Tantasawat, Hidefumi Kasai, et al.Personalized Medicine|May 18, 2018
Blood-direct InvaderPlus<sup>®</sup> as a new method for genetic testingAkira Hirasawa, Tomoko Akahane, Yusuke Tanigawara, et al.Journal of Clinical Pharmacology|November 25, 2010
Model-based analysis of covariate effects on population pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation and normal subjectsKazuhisa Tsuruta, Yoshinobu Yamada, Masashi Serada, et al.Drug Metabolism and Pharmacokinetics|September 12, 2009
Comparative pharmacodynamics of olmesartan and azelnidipine in patients with hypertension: a population pharmacokinetic/pharmacodynamic analysisYusuke Tanigawara, Kazutaka Yoshihara, Kizuku Kuramoto, et al.Journal of Clinical Pharmacology|August 5, 2015
Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazoleChiyo K Imamura, Kenichi Furihata, Shinichiro Okamoto, et al.Journal of Clinical Pharmacology|November 2, 2020
Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic AcidHidefumi Kasai, Yoko Mori, Atsushi Ose, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 21, 2011
Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic-pharmacodynamic analysisYuka Ohata, Yoshiko Tomita, Mitsunobu Nakayama, et al.Biological & Pharmaceutical Bulletin|January 8, 2004
Phorbol myristate acetate stimulates degradation of a structural analogue of platelet-activating factor to a neutral lipid in human leukemic K562 cells: relevance to the release of lipidsToshihiko Tsutsumi, Akira Tokumura, Masaya Yamaguchi, et al.Journal of Clinical Pharmacology|June 15, 2017
Population Pharmacokinetic and Exposure-Response Analysis of Weekly Teriparatide in Osteoporosis PatientsAtsushi Ose, Masashi Serada, Keiko Yamashita, et al.Pageof 10